🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Pyoderma Gangrenosum

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum NCT07337564Phase 21 site📍 Jinan Shandong First Medical University · Tests: SHR-1139 Injection A Real-World Registry of Chronic Wounds and Ulcers NCT02280733n/a1 site📍 The Woodlands U.S. Wound Registry · Tests: Usual care A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum NCT06624670Phase 3104 sites📍 Birmingham📍 Phoenix📍 Irvine LEO Pharma · Tests: Spesolimab, Placebo matching to spesolimab, Prednisone, Prednisolone Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum NCT07783412Phase 21 site📍 Portland Oregon Health and Science University · Tests: topical ruxolitinib 1.5% cream
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy